In the case of SG2, the proteins fibronectin and LGALS3BP were enriched and have also been involved in breast cancer progression and considered as prognostic markers (Läubli et al., 2014; Moon et al., 2016; Stampolidis et al., 2015). This evidence concerns the gene LGALS3BP and breast carcinoma.